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Early identification of persons at risk for cognitive decline in aging is critical to optimizing
treatment to delay or avoid a clinical diagnosis of mild cognitive impairment (MCI)
or dementia due to Alzheimer’s disease (AD). To accomplish early identification, it is
essential that trajectories of cognitive change be characterized and associations with
established biomarkers of MCI and AD be examined during the phase in which older
persons are considered cognitively healthy. Here we examined the association of rate of
cognitive decline in the years leading up to structural magnetic resonance imaging with an
established biomarker, hippocampal volume. The sample comprised 211 participants of the
Rush Memory and Aging Project who had an average of 5.5 years of cognitive data prior to
structural scanning. Results showed that there was significant variability in the trajectories
of cognitive change prior to imaging and that faster cognitive decline was associated with
smaller hippocampal volumes. Domain-specific analyses suggested that this association
was primarily driven by decline in working memory. The results emphasize the importance
of closely examining cognitive change and its association with brain structure during the
years in which older persons are considered cognitively healthy.
Keywords: neuroimaging, macrostructure, hippocampal volume, aging, dementia, Alzheimer’s disease, mild
cognitive impairment, Rush Memory and Aging Project
INTRODUCTION
Early identification of persons at risk for cognitive decline in aging
is critical to optimizing treatment to delay or avoid a clinical diag-
nosis of dementia due to Alzheimer’s disease (AD; Sloane et al.,
2002; Cummings et al., 2007). Accordingly, the diagnostic con-
tinuum of AD has recently been re-conceptualized to emphasize
clinical AD diagnosis as the final stage of the disease, and atten-
tion has shifted to characterizing cognitive and biologic markers
in a preclinical phase that can reliably identify those persons at
increased risk of ultimately developing clinical AD (Jack et al.,
2011; Sperling et al., 2011).
This preclinical phase, during which subtle cognitive changes
are occurring in some cognitively healthy older persons, can be
quite long, potentially lasting many years (Amieva et al., 2008;
Johnson et al., 2009; Wilson et al., 2011, 2012). Cognitively
healthy persons who are experiencing subtle cognitive decline
within the normal range may be undergoing a clinically-
silent pathological cascade of brain changes during this phase
(Mormino et al., 2008; Jack et al., 2010a,b; Bennett et al., 2012b).
One of those brain changes, hippocampal atrophy, is thought to
occur late in this cascade (Sperling et al., 2011) and, when it is
associated with overt cognitive impairment, may mark the transi-
tion out of the preclinical phase. Indeed, the association between
hippocampal atrophy and mild cognitive impairment (MCI) and
AD is a well-established finding in cross-sectional and prospec-
tive longitudinal studies (e.g., Mungas et al., 2002; Chetelat and
Baron, 2003; Jack et al., 2010b; Risacher et al., 2010; Sperling et al.,
2011; Van Rossum et al., 2012).
The association between hippocampal atrophy and cognitive
function in cognitively healthy persons in both cross-sectional
and prospective longitudinal studies, however, is not as clear.
Medial-temporal, including hippocampal, volume loss has been
reported and associated with cognitive function in a number
of studies of older persons considered cognitively normal (e.g.,
Mu et al., 1999; Tisserand et al., 2000; Raz et al., 2005; Mungas
et al., 2005; Du et al., 2006; Tupler et al., 2007; Head et al., 2008;
Dickerson et al., 2009; Raji et al., 2009; Fjell et al., 2010b;Walhovd
et al., 2011; Rosano et al., 2012), but just as many other studies
find that this association is weak or not present (e.g., Raz et al.,
1997; Good et al., 2001; Resnick et al., 2003; Salat et al., 2004; Van
Petten, 2004; Allen et al., 2005; Fjell et al., 2009, 2010a; Lo et al.,
2011; Lemaitre et al., 2012).
Frontiers in Aging Neuroscience www.frontiersin.org June 2013 | Volume 5 | Article 21 | 1
AGING NEUROSCIENCE
Fleischman et al. Cognitive change prior to imaging
There are at least three important reasons for the mixed find-
ings. First, studies do not always distinguish between subjects
who are and are not declining in cognitive function within the
normal range. As a result, samples across studies may differ in
the number of subjects included that are considered cognitively
healthy but may be declining. Second, in longitudinal studies, the
number of data collection time points is often limited. Given the
length of the preclinical phase, multiple years of testing may be
needed to identify those persons that are declining cognitively.
Third, in a cognitively healthy group, there can be ceiling effects
in cognitive function depending on the scale chosen to measure
it. For example, ceiling effects have been demonstrated for AD
patients on the frequently used Alzheimer’s Disease Assessment
Scale-cognitive subscale (ADAS-cog), an 11-item summary mea-
sure (Hobart et al., 2013), and it is quite likely that the scale is
not sensitive to subtle compromise or change in cognitive func-
tion within the normal range (Hobart et al., 2013). Further, using
a single measure of global cognitive function limits what can be
learned about specific aspects of cognitive function and cognitive
decline that may be associated with brain integrity. Thus, there
is a need for a longitudinal study that examines the association
between hippocampal atrophy, a well-established biomarker for
MCI and AD, and change in cognition during the phase when
older persons are considered cognitively healthy, across many
cycles during this protracted phase, using measures of global
and specific domains of cognition that are known to be sen-
sitive to change within the normal range (Wilson et al., 2011,
2012).
In this study, we examined cognitive change and its associ-
ation with hippocampal atrophy during the cognitively healthy
years leading up to structural imaging. The Rush Memory and
Aging Project, a longitudinal cohort study of aging and dementia
began in 1997 and introduced neuroimaging in 2009. Therefore,
we were able to measure the rate of global cognitive change, as
well as the rate of change in five specific cognitive systems, in
multiple years leading up to structural brain imaging in clinically
well-characterized persons who did not have MCI or dementia
at time of scan. We tested the hypothesis that older persons who
experienced faster decline in cognition, but who were still consid-
ered cognitively healthy at the time of scan, would have smaller
hippocampal volumes.
MATERIALS AND METHODS
SUBJECTS
The subjects are participants in an on-going longitudinal cohort
study of aging and dementia. The Rush Memory and Aging
Project, which began in 1997, has a rolling admission and requires
annual clinical evaluation and brain donation at death (Bennett
et al., 2012a). Neuroimaging was introduced into the study in
2009. The study is approved by the institutional review board of
Rush University Medical Center.
At the time of analyses, 1528 participants had enrolled and
completed their baseline evaluation: 564 died, 107 refused fur-
ther participation in either the parent study or neuroimaging
substudy before scan data could be collected, and 342 were not
eligible for the scan due to various reasons including MRI con-
traindications. Of the remaining 515, 440 were scanned and 75
were being scheduled for scanning. Of the 440 that were scanned,
414 had data on hippocampal volume, of which 8 were demented
at scan and 138 had only one cognitive data point prior to scan.
Of the remaining 268, 57 had MCI and 211 were cognitively
normal.
CLINICAL EVALUATION
All participants underwent an annual uniform and structured
clinical evaluation that included a medical history, complete
neurological examination, and cognitive performance testing.
Based on these data and in-person evaluation of the subjects,
an experienced clinician diagnosed dementia and AD using the
criteria of the joint working group of the National Institute of
Neurologic and Communicative Disorders and Stroke and the
AD and Related Disorders Association (McKhann et al., 1984).
The criteria require a history of cognitive decline and impairment
in at least two cognitive domains, one of which must be mem-
ory for a diagnosis of AD. As previously described (Bennett et al.,
2012a), impairment in five cognitive domains (orientation, atten-
tion, memory, language, and visuospatial ability) was determined
in a two-step process. First, an algorithm rated impairment in
each domain based on educationally-adjusted cutoff scores on 11
individual tests. Second, based on all test data and information on
education, sensorimotor problems, and effort, a neuropsychol-
ogist agreed, or disagreed with each rating and supplied a new
rating in the event of disagreement. Persons who had cognitive
impairment but did not meet criteria of dementia were classi-
fied as having MCI. All clinical classification was done blinded
to previously collected data.
COGNITIVE EVALUATION
A battery of 21 cognitive performance tests was administered
in an approximately hour-long session during baseline and
annual follow-up sessions. The Mini-Mental State Examination
(MMSE) was used as an overall measure of cognitive ability
and one test (Complex Ideational Material) was only used for
diagnostic classification (Bennett et al., 2012a). Episodic mem-
ory measures included Word List Memory, Word List Recall
and Word List Recognition from the procedures established by
the CERAD, immediate and delayed recall of Logical Memory
Story A and the East Boston Story. Semantic memory mea-
sures included Verbal Fluency, Boston Naming, and a subset
of items from the National Adult Reading Test. Working mem-
ory measures included the Digit Span subtests (forward and
backward) of the Wechsler Memory Scale-Revised and Digit
Ordering. Measures of perceptual speed included the oral version
of the Symbol Digit Modalities Test, Stroop Test, and Number
Comparison. Measures of visuospatial ability included Judgment
of Line Orientation and Standard Progressive Matrices. Raw
scores on each test were converted to standard z scores using
the mean and standard deviation from the baseline evaluation.
A person’s standard scores across 19 tests were averaged to yield
a single overall cognitive composite score. A composite score
for five cognitive domains (episodic memory, semantic memory,
working memory, perceptual speed, visuospatial ability) was cre-
ated by averaging the z-scores of all measures within a domain
(Bennett et al., 2012a).
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MRI ACQUISITION AND POST-PROCESSING
MRI scans were performed on a 1.5 Tesla General Electric
MRI scanner (GE, Waukesha, WI). High-resolution T1-
weighted anatomical data was obtained for all subjects using
a 3D magnetization-prepared rapid acquisition gradient-
echo (MPRAGE) sequence with the following parameters:
TE = 2.8ms, TR = 6.3ms, preparation time = 1000ms, flip
angle 8◦, field-of-view 24 cm × 24 cm, 160 sagittal slices, 1mm
slice thickness, no gap, 224 × 192 image matrix reconstructed
to 256 × 256, scan time = 10min and 56 s. Two copies of
the T1-weighted data were acquired on each subject. The two
T1-weighted datasets from each subject were co-registered using
rigid-body registration and averaged. The average T1-weighted
dataset of each subject was then segmented using FreeSurfer
Version 5 (http://surfer.nmr.mgh.harvard.edu; Fischl et al.,
2002; Xiao and Fischl, 2007). The results were reviewed and any
errors were manually corrected. The volume of the segmented
gray matter regions, including the hippocampus, and the total
intracranial volume (ICV) were estimated for each subject. The
volumes of homologous regions in contralateral hemispheres
were averaged. Finally, hippocampal and all other volumes were
normalized by dividing by the total ICV.
Daily quality assurance tests were conducted on the scanner
according to the American College of Radiology (ACR) protocol.
The data from these tests were used to evaluate the performance
of the MRI scanner hardware on days data on human subjects
was collected. An algorithm developed in-house was used to
automatically produce the results of the quality assurance tests.
Furthermore, the whole brain signal to noise ratio (SNR), and
the contrast to noise ratio (CNR) between white and gray mat-
ter were estimated for the average T1-weighted dataset of each
subject. The mean and standard deviation of the SNR and CNR
were calculated over all subjects. Individual datasets with SNR or
CNR lower than two standard deviations from the mean SNR
and CNR over all subjects were inspected for potential prob-
lems in the raw data or with automated brain segmentation.
Finally, the data were inspected for outliers in ICV-normalized
volumes.
STATISTICAL APPROACH
To investigate the temporal association between the pre-scan rate
of change in cognition with total hippocampal volume, we first
estimated the slope of cognitive decline for each individual by
fitting a linear mixed model to all available longitudinal cogni-
tive testing data up until the time of neuroimaging, adjusted for
age, sex, and years of education. These person-specific slopes were
then used in ordinary linear regression as the predictor for hip-
pocampal volume. All subsequent regression models were also
adjusted for age at scan, sex, and education.
We first examined the association of pre-scan rate of change
in global cognition with hippocampal volume. Next, because it is
possible that the association may differ across cognitive domains,
in subsequent analyses, we examined the association of the rates
of change in five different cognitive domains of episodic mem-
ory, semantic memory, working memory, perceptual speed, and
visuospatial ability with hippocampal volume. Finally, because
the presence of vascular disease burden or vascular disease risk
might influence the association of pre-scan change in cognition
with the hippocampal volume, in secondary analyses we aug-
mented our core model by adding covariates for vascular disease
burden (a composite score of vascular diseases including claudi-
cation, stroke, heart conditions, and congestive heart failure) as
well as vascular disease risk (a composite score of vascular dis-
ease risk factors including hypertension, smoking and diabetes).
We imposed a nominal threshold of p < 0.05 for statistical signif-
icance and all analyses were implemented using SAS® software,
version 9.3 (SAS Institute Inc., 2012).
RESULTS
Two hundred and eleven subjects participating in the Rush
Memory and Aging Project were included in the analysis.
Descriptive characteristics of the group are provided in Table 1.
The mean age at scan was 82.7 years (SD = 6.7, range =
65.2–100.3). The average length of follow-up prior to imaging
was 5.5 years (SD = 2.7, range = 0.6–13.0). Comparing this sam-
ple with the subjects that were scanned but were excluded from
the analysis due to dementia or lack of follow-up data, we found
no significant differences between the two samples in age, sex,
or education. Subjects that were excluded from the analysis had,
on average, lower global cognitive function (p-value < 0.001)
and fewer vascular diseases (p-value < 0.001). The difference in
vascular disease risk was marginal (p-value = 0.086).
Quality assurance testing demonstrated that scanner perfor-
mance was satisfactory and consistent. The SNR and CNR of all
datasets included in this study exceeded the minimum acceptable
limits. No outliers in ICV-normalized hippocampal volumes were
identified.
Average ICV-normalized hippocampal volumewas 4.1 × 10−3
(SD = 0.7 × 10−3, range = 2.7 × 10−3 to 6.5 × 10−3). Simple
correlation analyses revealed that hippocampal volume was
negatively associated with age at scan (r = −0.57, p < 0.001)
and positively associated with global cognition at scan (r =
0.26, p < 0.001) and MMSE score (r = 0.26, p < 0.001).
Hippocampal volume was not related to years of education. In
this group, females had larger hippocampal volumes than males
(Diff = 0.36 × 10−3, t = 3.87, df = 128.3, p < 0.001).
To examine the association of pre-scan rate of change in cog-
nitive function with hippocampal volume, we first constructed a
linear mixed-effects model with a term for time (since baseline
Table 1 | Descriptive characteristics of the participants in the study
(N = 211).
Mean (SD)/N (%)
Age at scan (years) 82.7 (6.7)
Education (years) 15.3 (3.1)
Female 154 (73.0%)
MMSE at scan 28.7 (1.3)
Global cognitive score at scan 0.38 (0.44)
Total hippocampal volume (× 10−3) 4.1 (0.7)
Pre-scan follow-up years 5.5 (2.7)
At least one vascular disease 82 (38.9%)
At least one vascular risk factor 170 (80.6%)
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in years) to estimate each person’s annual rate of global cognitive
change (i.e., slope), adjusted for age, sex, and education. On aver-
age there was no overall decline in global cognition (Estimate =
−0.004, SE = 0.004, p = 0.273). However, since some persons
declined, others remained the same, and still others improved
as a result of practice and learning, the variance estimate for
person-specific slopes was highly significant (Estimate = 0.0007,
SE = 0.0002, p < 0.001). Figure 1 illustrates the predicted linear
decline in global cognition for a randomly-selected sample of 20
persons. Figure 2 further illustrates the distribution of person-
specific pre-scan rates of decline (Mean = −0.005, SD = 0.019,
range = −0.057 to 0.039). As shown by these figures, even among
FIGURE 1 | Predicted linear decline in global cognition for a
randomly-selected sample of 20 persons.
FIGURE 2 | Distribution of person-specific pre-scan rates of decline.
these cognitively healthy persons, there is a sizeable amount of
variability in the rates of decline: some persons declined faster,
some slower, while other persons improved slightly.
To illustrate the difference in hippocampal volumes between
cognitively healthy persons with declining slopes (cognitive
decliners, 57.8% of the sample) and cognitively healthy persons
with non-negative slopes (cognitive maintainers, 42.2% of the
sample), we present a prism-like plot showing the mean differ-
ence in hippocampal volume between the groups. Figure 3 shows
that persons who declined in cognitive function prior to time of
scan had on average smaller hippocampal volumes.
Next, to formally test the hypothesis that faster rate of decline
in global cognitive function prior to scan was associated with
smaller hippocampal volume, we constructed a linear regression
model with hippocampal volume as the outcome and terms for
global cognitive slope, age at scan, sex, and education as the pre-
dictors. The result of this analysis showed that a more rapid rate
of pre-scan cognitive decline was associated with smaller hip-
pocampal volume (p = 0.019; Table 2). To clarify the magnitude
FIGURE 3 | Mean difference in hippocampal volume between cognitive
decliners and cognitive maintainers.
Table 2 | Pre-scan rate of change in cognition and hippocampal
volume.
Cognitive measures Estimates* (SE), p
Global cognition 0.055 (0.023), 0.019
Episodic memory 0.033 (0.017), 0.059
Semantic memory 0.042 (0.045), 0.347
Working memory 0.065 (0.027), 0.017
Perceptual speed 0.017 (0.010), 0.112
Visuospatial ability −0.106 (0.129), 0.414
*Estimates refer to the increase in hippocampal volume (× 10−3) with every 0.01
unit increase in rate of change in cognition. All the models were adjusted for age
at scan, sex, and years of education.
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of this effect, when the rate of pre-scan decline in global cogni-
tion increased by 1 standard deviation, the average reduction in
total hippocampal volume was equivalent to an increase of about
2 years of age. The results were unchanged after adjusting for
vascular disease burden and vascular disease risk.
Finally, we examined the association of rates of change in
domain-specific summarymeasures of cognition with hippocam-
pal volume. Analyses of five different cognitive domains indicated
that smaller hippocampal volume was associated with faster pre-
scan decline in working memory (p = 0.017). There was also
a strong trend for smaller hippocampal volume to be asso-
ciated with pre-scan decline in episodic memory (p = 0.059).
Hippocampal volume was not associated with pre-scan decline
in semantic memory, perceptual speed or visuospatial ability.
DISCUSSION
The results of this study demonstrate that when cognition is fully
characterized over a sufficient period of time during the phase
when older persons are considered cognitively healthy, substantial
individual variability in slopes of cognitive change is observed and
a faster rate of cognitive decline, particularly in working mem-
ory, can be linked to hippocampal atrophy, a well-established
biomarker of risk for MCI and/or AD.
Our findings are consistent with a number of studies that
report cognitive decline in the healthy years preceding a clin-
ical diagnosis of MCI and/or AD (e.g., Amieva et al., 2008;
Johnson et al., 2009; Wilson et al., 2011, 2012; Rosano et al.,
2012) and extend these results by underscoring the substantial
variability in cognitive function that occurs within the normal
range during these years. It is clear that some persons decline,
some stay stable and others improve, and this heterogeneity may
be one explanation for mixed findings regarding the relation-
ship of cognitive decline to measures of brain integrity in the
cognitively healthy years. In this study, those persons who were
cognitively healthy at the time of scan, but who declined cogni-
tively in the years preceding the scan, had smaller hippocampal
volumes.
We measured cognitive decline globally, but also in five dif-
ferent domains, and found that the association with smaller hip-
pocampal volume was driven most strongly by decline in working
memory. This finding is in line with studies that have connected
the soundness of working memory in aging to the integrity of the
hippocampal region (reviewed in Salthouse, 2011). However, the
association between episodic memory and hippocampal atrophy
was weaker, a finding that is often noted in studies of cognitively
healthy older persons (reviewed in Van Petten, 2004). When we
separated our sample into domain-related decliners and main-
tainers, the percentage of working memory-decliners was quite
high (97%) and the association with hippocampal atrophy was
strong, whereas the percentage of episodic memory-decliners was
quite low (14%) and the association with hippocampal atrophy
was marginal. Again, these findings emphasize the importance
of addressing sample composition in longitudinal studies of cog-
nition and brain integrity in cognitively healthy older persons.
Most importantly, however, they suggest that older persons who
are considered cognitively healthy but have evidence of cog-
nitive decline, particularly in working memory, may be amid
a pathological cascade and on a protracted trajectory toward
neuronal injury, episodic memory impairment and eventually a
clinical diagnosis of MCI or AD.
It has been established in many studies that maintaining cog-
nitive function in older age lowers the risk of adverse cognitive
and functional outcomes (reviewed in Hertzog et al., 2009),
however, the association of cognitive maintenance with brain
integrity is not well-studied. Only one study that we know of
has examined the relationship of cognitive maintenance to brain
integrity in cognitively healthy older persons in the years prior
to imaging. Rosano et al. (2012) reported that 59% of persons
in their sample maintained global cognitive function, based on
the Modified Mini-Mental State Examination (3MS; Teng and
Chui, 1987), over 4 time points in the decade prior to time
of scan. Cognitive maintainers had larger medial temporal lobe
(hippocampus, parahippocampus, entorhinal cortex) gray mat-
ter volumes. The results of the current study support this finding
in that global cognitive maintainers (42.2% of our sample) had
larger hippocampal volumes compared to cognitive decliners.
However, the possibility that cognitive maintenance reflects sus-
ceptibility to practice effects needs to be addressed. We examined
this possibility in secondary analyses using scores from the cog-
nitive domain that generated the largest percentage of cognitive
maintainers, episodic memory (86%). We added additional terms
to the linear mixed models representing the number of follow-up
years of cognitive testing, as previously reported (Wilson et al.,
2006). We found some evidence of a practice effect on episodic
memory, however, the percentage of episodic memory main-
tainers still reached 60% after adjusting for this practice effect.
This suggests that these individuals are genuinely maintaining or
improving their episodic memory. A number of lifestyle behav-
iors that can potentially protect cognition have been examined
(reviewed in Hertzog et al., 2009). For example, it has been shown
that frequent mental stimulation leads to better cognitive func-
tion (Wilson et al., 2012), particularly in episodic memory. More
studies are needed to further understand the brain basis of this
phenomenon.
This study has important strengths. The data were sampled
from a large, longitudinal clinical-pathological study in which
subjects have participated in up to 14 annual assessments using
well-established clinical and cognitive measures. The study also
has limitations. The period of time over which cognitive change
was measured in this study cannot be considered preclinical. All
subjects were cognitively healthy at time of scanning and we
await clinical outcomes. Although the Rush Memory and Aging
Project was designed to closely represent the general popula-
tion of persons aged 65 and over, the sample in this study was
selected. Multiple years of cognitive data allowed the examina-
tion of cognitive change, but the volume data are from one time
point. Thus, these data cannot address simultaneous change in
pre-scan cognition and hippocampal volume. However, partici-
pants of the Rush Memory and Aging Study agree to bi-annual
scanning until death so it will be possible to examine the associ-
ations between cognitive change, transition to clinical diagnoses,
and macrostructural change in the future. Hippocampal volume
in the elderly may be influenced by the presence of not only AD
pathology, but other pathologies such as hippocampal sclerosis
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(Dawe et al., 2011), Lewy bodies (Burton et al., 2012), and amy-
loid angiopathy (Jagust et al., 2008; Erten-Lyons et al., 2013).
Although we cannot address the neuropathology of reduced vol-
ume in this study, histopathologic information will be available
for these subjects in the future. Finally, a stronger magnet would
have allowed a closer examination of associations with hippocam-
pal volumes in specific subfields. Using a 4T magnet, the CA1
subfield has been shown to be most strongly affected by age,
particularly in the seventh decade (Mueller et al., 2006) and hip-
pocampal deformation was primarily attributable to CA1 volume
loss in a post-mortem imaging shape analysis of elderly persons
over the age of 65 (Dawe et al., 2011). Post-mortem imaging will
also be available for these subjects in the future. These limitations
notwithstanding, the results of this study are important for at
least two reasons. First, they emphasize the need to deeply char-
acterize cognition, brain structure and their relation during the
years in which older persons are considered cognitively healthy.
Second, the findings are clinically relevant. Whereas clinicians
often use imaging biomarkers such as hippocampal volume to
predict subsequent cognitive decline, these findings show that
hippocampal volume can inform on the trajectory of cognitive
change during the period of time preceding the patient’s first pre-
sentation to the clinic. This information would help the clinician
elucidate the patient’s cognitive history, identify risk of developing
a clinical diagnosis of MCI or dementia due to AD and optimize
treatment.
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